期刊文献+

Serum-free media for articular chondrocytes in vitro expansion 被引量:4

Serum-free media for articular chondrocytes in vitro expansion
原文传递
导出
摘要 Background In vitro chondrocyte expansion is a major challenge in cell-based therapy for human articular cartilage repair. Classical culture conditions usually use animal serum as a medium supplement, which raises a number of undesirable questions. In the present study, two kinds of defined, serum-free media were developed to expand chondrocytes in monolayer culture for the purpose of cartilage tissue engineering. Methods Bovine chondrocytes were expanded in serum-free media supplemented with fibroblast growth factor-2 and platelet-derived growth factor or fibroblast growth factor-2 and insulin-like growth factor. Expansion culture in a conventional 10% fetal bovine serum (FBS) medium served as control. Fibronectin coating was used to help cell adhesion in serum-free medium. Next, in vitro three-dimensional pellet culture was used to evaluate the chondrocyte capacity. Cell pellets were expanded in different media to re-express the differentiated phenotype (re-differentiation) and to form cartilaginous tissue. The pellets were assessed by glycosaminoglycans contents, collagen II, collagen I and collagen X immunohistological staining. Results Chondrocytes cultured in serum-free media showed no proliferation difference than cells grown with 10% FBS medium. In addition, chondrocytes expanded in both serum-free media expressed more differentiated phenotypes at the end of monolayer culture, as indicated by higher gene expression ratios of collagen type II to collagen type I. Pellets derived from chondrocytes cultured in both serum-free media displayed comparable chondrogenic capacities to pellets from cells expanded in 10% FBS medium. Conclusion These findings provide alternative culture approaches for chondrocytes in vitro expansion, which may benefit the clinical use of autologous chondrocytes implantation. Background In vitro chondrocyte expansion is a major challenge in cell-based therapy for human articular cartilage repair. Classical culture conditions usually use animal serum as a medium supplement, which raises a number of undesirable questions. In the present study, two kinds of defined, serum-free media were developed to expand chondrocytes in monolayer culture for the purpose of cartilage tissue engineering. Methods Bovine chondrocytes were expanded in serum-free media supplemented with fibroblast growth factor-2 and platelet-derived growth factor or fibroblast growth factor-2 and insulin-like growth factor. Expansion culture in a conventional 10% fetal bovine serum (FBS) medium served as control. Fibronectin coating was used to help cell adhesion in serum-free medium. Next, in vitro three-dimensional pellet culture was used to evaluate the chondrocyte capacity. Cell pellets were expanded in different media to re-express the differentiated phenotype (re-differentiation) and to form cartilaginous tissue. The pellets were assessed by glycosaminoglycans contents, collagen II, collagen I and collagen X immunohistological staining. Results Chondrocytes cultured in serum-free media showed no proliferation difference than cells grown with 10% FBS medium. In addition, chondrocytes expanded in both serum-free media expressed more differentiated phenotypes at the end of monolayer culture, as indicated by higher gene expression ratios of collagen type II to collagen type I. Pellets derived from chondrocytes cultured in both serum-free media displayed comparable chondrogenic capacities to pellets from cells expanded in 10% FBS medium. Conclusion These findings provide alternative culture approaches for chondrocytes in vitro expansion, which may benefit the clinical use of autologous chondrocytes implantation.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第13期2523-2529,共7页 中华医学杂志(英文版)
关键词 articular chondrocyte serum-free media in vitro articular chondrocyte serum-free media in vitro
  • 相关文献

参考文献28

  • 1Hunziker EB. Articular cartilage repair: problems and perspectives. Biorheology 2000; 37:163-164.
  • 2Simon LS. Osteoarthritis: a review. Clin Cornerstone 1999; 2: 26-37.
  • 3Temenoff JS, Mikos AG. Review: tissue engineering for regeneration of articular cartilage. Biomaterials 2000; 21:431- 440.
  • 4Marlovits S, Zeller P, Singer P, Resinger C, Vecsei V. Cartilage repair: generations of autologous chondrocyte transplantation. Eur J Radio12006; 57: 24-31.
  • 5Hunziker EB. Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis Cartilage 2002; 10: 432-463.
  • 6van der Kraan PM, Buma P, van Kuppevelt T, van den Berg WB. Interaction of chondrocytes, extracellular matrix and growth factors: relevance for articular cartilage tissue engineering. Osteoarthritis Cartilage 2002; 10:631-637.
  • 7Benya PD, Padilla SR, Nimni ME. Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture. Cell 1978; 15: 1313-1321.
  • 8Malpeli M, Randazzo N, Cancedda R, Dozin B. Serum-free growth medium sustains commitment of human articular chondrocyte through maintenance of Sox9 expression. Tissue Eng 2004; 10: 145-155.
  • 9Pei M, Seidel J, Vunjak-Novakovic G, Freed LE. Growth factors for sequential cellular de- and re-differentiation in tissue engineering. Biochem Biophys Res Commun 2002; 294: 149- 154.
  • 10Jakob M, Demarteau O, Schafer D, Hintermann B, Dick W, Heberer M, et al. Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro. J Cell Biochem 2001; 81 : 368-377.

同被引文献35

  • 1王永民,陈昭烈.动物细胞无血清培养基的研究与设计方法[J].中国生物工程杂志,2007,27(1):110-114. 被引量:15
  • 2Pardee Ab. G1 event and regulation of cell proliferation[J]. Sci ence, 1989,246 : 603.
  • 3Hayden A,Johnson PWM,Packham G,et al. S-adenosylhomoeys-teine hydrolase inhibition by 3-deazaneplanocin A analogues in- duces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition[J]. Breast cancer research and treatment, 2011,127 (1) : 109.
  • 4Saito Y, Miyahara R, Gopalan B, et al. Selective induction of cell cycle arrest and apoptosis in human prostate cancer cells through adenoviral transfer of the melanoma differentiation-associated-7 (mda-7)/interleukin-24 (IL-24) gene [ J ]. Cancer gene therapy, 2005,12(3) :238.
  • 5Kikuchi H, Yuan B, Nishimura Y, et al. Cytotoxicity of Vitex ag- nus-castus fruit extract and its major component, casticin, corre- lates with differentiation status in leukemia cell lines[J]. Interna- tional Journal of Oncology,2013,43(6) :1976.
  • 6Blumberg. Protein Kinase C as the Receptor for the Phorbol Ester Tumor Promoters: Sixth Rhoads Memorial Award Lecturel [J]. Cancer Research, 1988,48 : 1.
  • 7Zhou L,Shen L, Hu L, et al. Retinoid X receptor agonists inhibit phorbol-12- myristate- 13-acetate (PMA)-induced differentiation of monocytie THP-I cells into macrophages[J]. Molecular and cellular biochemistry, 2010,335 (1-2) : 283.
  • 8Jalagadugula G,Dhanasekaran D N, Rao A K. Phorbol 12-Myris- tate 13 Acetate (PMA) Responsive Sequence in Gaq Promoter During Megakaryocytie Differentiation:Regulation by EGR-1 and MAP Kinase Pathway[J]. Thrombosis and haemostasis, 2008, 100(5) :821.
  • 9Huo XF, Yu J, Peng H, et al. Differential expression changes in K562 cells during the hemin-induced erythroid differentiation and the phorbol myristate acetate (PMA)-induced megakaryocytic differentiation[J]. Molecular and cellular biochemistry, 2006,292 (1-2),155.
  • 10Gottipamula S, Muttigi MS, Kolkundkar U, et al. Serum-free media for the production of human mesenchymal stromal cells: a review[J]. Cell Proliferation,2013,doi: 10. 1111/cpr. 12063.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部